Del. High Court Reverses Appriva Investors' $250M Ev3 Win
The Delaware Supreme Court on Tuesday ruled a trial court should not have allowed Appriva Medical Inc. shareholders to argue a nonbinding letter of intent affected a merger agreement with ev3...To view the full article, register now.
Already a subscriber? Click here to view full article